Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04958798 · ClinicalTrials.gov registry record · NA
Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities
A NA study of Opioid Use Disorder, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 3
- Study locations
NCT04958798: Completed NA study of Opioid Use Disorder, sponsored by New York State Psychiatric Institute.
NCT04958798 is a NA study of Opioid Use Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 48 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04958798, a NA study of Opioid Use Disorder, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a formative research study to test a culturally-centered, program-level implementation intervention to increase the use of medications for opioid use disorder in four healthcare and addiction specialty treatment sites serving American Indian and Alaska Native communities.
Primary Outcome
The primary outcome is comprised of de-identified EMR data comparing MOUD initiation pre-intervention to post-intervention time periods with offset terms for time and clinic size.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Centered MOUD Implementation Intervention
Study Locations (3)
Alaska
- Southcentral Foundation - Anchorage
Minnesota
- Native American Community Clinic - Minneapolis
South Dakota
- Missouri Breaks - Eagle Butte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2021-12-20 |
| Est. Completion | 2025-01-16 |
| Phase | NA |
What the finished NCT04958798 record still lists
NCT04958798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Culturally Centered MOUD Implementation Intervention is the first listed.
NCT04958798 reports a single indexed study location in Alaska, Minnesota, South Dakota.
Frequently Asked Questions
What is clinical trial NCT04958798 about?
NCT04958798 is a clinical study titled "Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities". This is a formative research study to test a culturally-centered, program-level implementation intervention to increase the use of medications for opioid use disorder in four healthcare and addiction specialty treatment sites serving American Indian and Alaska Native communities.
What is the current status of trial NCT04958798?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2021-12-20. Estimated completion is 2025-01-16.
What conditions does trial NCT04958798 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04958798?
The interventions under investigation include: Culturally Centered MOUD Implementation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04958798?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04958798 being conducted?
This trial has 3 study locations across Alaska, Minnesota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04958798's enrollment target sits among peer trials
48 179th of 257 higher than 79 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI